Llwytho...
Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions
BACKGROUND AND PURPOSE: Telmisartan suppresses the development of endometriotic lesions. However, the drug also up‐regulates the expression of COX‐2, which has been suggested to promote the progression of endometriosis. Accordingly, in the present study we analysed whether a combination therapy with...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Br J Pharmacol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5522992/ https://ncbi.nlm.nih.gov/pubmed/28548231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13874 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|